234 related articles for article (PubMed ID: 29785476)
1. Vaccinia Virus Protein C6: A Multifunctional Interferon Antagonist.
Smith GL
Adv Exp Med Biol; 2018; 1052():1-7. PubMed ID: 29785476
[TBL] [Abstract][Full Text] [Related]
2. Vaccinia Virus Protein C6 Inhibits Type I IFN Signalling in the Nucleus and Binds to the Transactivation Domain of STAT2.
Stuart JH; Sumner RP; Lu Y; Snowden JS; Smith GL
PLoS Pathog; 2016 Dec; 12(12):e1005955. PubMed ID: 27907166
[TBL] [Abstract][Full Text] [Related]
3. Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.
Arndt WD; Cotsmire S; Trainor K; Harrington H; Hauns K; Kibler KV; Huynh TP; Jacobs BL
J Virol; 2015 Oct; 89(20):10489-99. PubMed ID: 26246580
[TBL] [Abstract][Full Text] [Related]
4. The Host Restriction Factor Interferon-Inducible Transmembrane Protein 3 Inhibits Vaccinia Virus Infection.
Li C; Du S; Tian M; Wang Y; Bai J; Tan P; Liu W; Yin R; Wang M; Jiang Y; Li Y; Zhu N; Zhu Y; Li T; Wu S; Jin N; He F
Front Immunol; 2018; 9():228. PubMed ID: 29503647
[TBL] [Abstract][Full Text] [Related]
5. Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8
Pallett MA; Ren H; Zhang RY; Scutts SR; Gonzalez L; Zhu Z; Maluquer de Motes C; Smith GL
J Virol; 2019 May; 93(10):. PubMed ID: 30814284
[TBL] [Abstract][Full Text] [Related]
6. The amino terminus of the vaccinia virus E3 protein is necessary to inhibit the interferon response.
White SD; Jacobs BL
J Virol; 2012 May; 86(10):5895-904. PubMed ID: 22419806
[TBL] [Abstract][Full Text] [Related]
7. RNA-Seq Based Transcriptome Analysis of the Type I Interferon Host Response upon Vaccinia Virus Infection of Mouse Cells.
Hernáez B; Alonso G; Alonso-Lobo JM; Rastrojo A; Fischer C; Sauer S; Aguado B; Alcamí A
J Immunol Res; 2017; 2017():5157626. PubMed ID: 28280747
[TBL] [Abstract][Full Text] [Related]
8. Human FAM111A inhibits vaccinia virus replication by degrading viral protein I3 and is antagonized by poxvirus host range factor SPI-1.
Zhu J; Gao X; Li Y; Zhang Z; Xie S; Ren S; Li Y; Li H; Niu K; Fu S; Deng Y; Li Y; Moss B; Wu W; Peng C
Proc Natl Acad Sci U S A; 2023 Aug; 120(35):e2304242120. PubMed ID: 37607234
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Temporal Proteomic Analysis of Vaccinia Virus Infection Reveals Regulation of Histone Deacetylases by an Interferon Antagonist.
Soday L; Lu Y; Albarnaz JD; Davies CTR; Antrobus R; Smith GL; Weekes MP
Cell Rep; 2019 May; 27(6):1920-1933.e7. PubMed ID: 31067474
[TBL] [Abstract][Full Text] [Related]
10. Type I interferon-dependent CCL4 is induced by a cGAS/STING pathway that bypasses viral inhibition and protects infected tissue, independent of viral burden.
Parekh NJ; Krouse TE; Reider IE; Hobbs RP; Ward BM; Norbury CC
PLoS Pathog; 2019 Oct; 15(10):e1007778. PubMed ID: 31603920
[TBL] [Abstract][Full Text] [Related]
11. Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling.
Price PJ; Torres-Domínguez LE; Brandmüller C; Sutter G; Lehmann MH
Vaccine; 2013 Sep; 31(39):4231-4. PubMed ID: 23523404
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 4 promotes type I interferon signaling, restricts DNA viruses, and is degraded via vaccinia virus protein C6.
Lu Y; Stuart JH; Talbot-Cooper C; Agrawal-Singh S; Huntly B; Smid AI; Snowden JS; Dupont L; Smith GL
Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11997-12006. PubMed ID: 31127039
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State.
Liu R; Moss B
J Virol; 2018 May; 92(9):. PubMed ID: 29444943
[TBL] [Abstract][Full Text] [Related]
14. Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism.
Pilna H; Hajkova V; Knitlova J; Liskova J; Elsterova J; Melkova Z
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696416
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence.
Strnadova P; Ren H; Valentine R; Mazzon M; Sweeney TR; Brierley I; Smith GL
PLoS Pathog; 2015 Sep; 11(9):e1005151. PubMed ID: 26334635
[TBL] [Abstract][Full Text] [Related]
16. Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity.
Smith GL; Benfield CTO; Maluquer de Motes C; Mazzon M; Ember SWJ; Ferguson BJ; Sumner RP
J Gen Virol; 2013 Nov; 94(Pt 11):2367-2392. PubMed ID: 23999164
[TBL] [Abstract][Full Text] [Related]
17. The interferon system and vaccinia virus evasion mechanisms.
Perdiguero B; Esteban M
J Interferon Cytokine Res; 2009 Sep; 29(9):581-98. PubMed ID: 19708815
[TBL] [Abstract][Full Text] [Related]
18. Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins.
Wyatt LS; Xiao W; Americo JL; Earl PL; Moss B
mBio; 2017 Jun; 8(3):. PubMed ID: 28588133
[TBL] [Abstract][Full Text] [Related]
19. Adaptive Immune Response to Vaccinia Virus LIVP Infection of BALB/c Mice and Protection against Lethal Reinfection with Cowpox Virus.
Shchelkunov SN; Sergeev AA; Yakubitskiy SN; Titova KA; Pyankov SA; Kolosova IV; Starostina EV; Borgoyakova MB; Zadorozhny AM; Kisakov DN; Shulgina IS; Karpenko LI
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452494
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA.
Ramírez M; Santos S; Martínez O; Rodríguez R; Miranda E; Ramos-Perez WD; Otero M
Vaccine; 2018 Apr; 36(15):2049-2055. PubMed ID: 29525282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
